Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$442.30 USD
-2.23 (-0.50%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $443.30 +1.00 (0.23%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Intuitive Surgical, Inc. (ISRG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$426.00 | $500.00 | $318.00 | -4.17% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for Intuitive Surgical, Inc. comes to $426.00. The forecasts range from a low of $318.00 to a high of $500.00. The average price target represents a decline of 4.17% from the last closing price of $444.53.
Analyst Price Targets (22)
Broker Rating
Intuitive Surgical, Inc. currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 24 brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on 24 recommendations.
Of the 24 recommendations deriving the current ABR, 15 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 62.5% and 8.33% of all recommendations. A month ago, Strong Buy made up 62.5%, while Buy represented 8.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ISRG.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 14 | 14 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 7 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.70 | 1.70 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/2/2024 | Evercore Partners | Vijay Kumar | Hold | Hold |
6/21/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/30/2024 | Goldman Sachs | David H Roman | Not Available | Strong Buy |
4/26/2024 | William Blair | Brandon Vazquez | Strong Buy | Strong Buy |
4/19/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
4/19/2024 | Not Identified | Not Identified | Hold | Hold |
4/19/2024 | Not Identified | Not Identified | Hold | Hold |
4/19/2024 | Piper Sandler | Adam C Maeder | Strong Buy | Strong Buy |
4/18/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
4/11/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
3/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
2/1/2024 | Robert W. Baird & Co. | David Rescott | Strong Buy | Strong Buy |
2/1/2024 | UBS | Danielle Antalffy | Hold | Hold |
1/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/25/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Hold | Hold |
1/24/2024 | Truist Securities | Richard Newitter | Strong Buy | Strong Buy |
1/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/19/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
11/17/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 24 |
Average Target Price | $426.00 |
LT Growth Rate | 16.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 145 of 252 |
Current Quarter EPS Est: | 1.53 |